MedTrace Logo

Shanghai Mild Cognitive Impairment Cohort Study

NCT01552265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-04-25

No results posted yet for this study

Summary

This study was planned 1) to identify individuals with Mild Cognitive Impairment (MCI) who convert to Alzheimer's Disease (AD), and 2) to explore factors associated with the conversion.

Conditions

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Yoji Nagai, MD,PhD · Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe,Japan

Eligibility

Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2017-02-28
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01552265 on ClinicalTrials.gov